Imagia’s EVIDENS collaboration ecosystem federates learning across hospital data and unites creative minds in AI and healthcare to power discovery at scale. This is enabled through established clinical collaborations and bolstered by a privileged research partnership with the Montreal Institute of Learning Algorithms (MILA), spearheaded by Yoshua Bengio.
EVIDENS – an accelerator
of clinical research
Imagia’s EVIDENS transforms routine clinical data, designed to deliver care, into outcome-based structured information appropriate for AI biomarker discovery.
EVIDENS is purpose-designed for clinical researchers and healthcare partners to use AI and validate clinical insights without needing to be AI experts. It enables clinical researchers from different institutions to collaborate on AI biomarker candidates.
Research projects through EVIDENS adhere to local ethic review boards and comply with regulations governing the protection of patient information.
Hospitals, research centers, pharmaceutical companies
EVIDENS is a unique collaborative AI ecosystem that gives hospitals, medical device manufacturers, pharmaceutical companies and diagnostic companies the opportunity to benefit from a broad clinical network and the ability to use personalized medicine to its fullest potential.